The shares have sprung back to life thanks to China’s new stimulus programs—and Alibaba’s AI ventures. They stand to gain as much as 48%.

In a report released today, Billy Boulton from Morgans maintained a Buy rating on Viva Leisure Ltd. (VVA – Research Report), with a price target of A$1.75. The company’s shares closed ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

RAMAT GAN, ISRAEL - XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) (TASE:XTLB.TA), a micro-cap company valued at $10.26 million with holdings in web data and biopharmaceutical intellectual property, ...

Citi analyst Paul McTaggart maintained a Buy rating on South32 Ltd. (S32 – Research Report) today and set a price target of A$4.00. The company’s shares closed today at p120.00. Discover ...

(RTTNews) - XTL Biopharmaceuticals Ltd. (XTLB) Monday announced the appointment of Noam Band as Chief Executive Officer. Band has previously served as the Chairman and CEO of Gix Internet Ltd. and ...